DOCEON contains docetaxel, an anti-cancer agent used in chemotherapy for treating various cancers, including breast cancer, lung cancer, and other types of tumors. Docetaxel works by interfering with cell division, stopping tumor cells from growing and causing their destruction. This drug is recommended as part of combination chemotherapy regimens for cancer treatment.
The product is used for:
Breast cancer
Non-small cell lung cancer
Head and neck cancer
Ovarian cancer
Treatment of other oncological diseases as prescribed by a doctor
DOCEON is administered intravenously, typically once every 3 weeks, with the dosage determined by the doctor based on the patient's condition and type of cancer. The drug is infused slowly via an IV drip, and the dosage may be adjusted depending on the patient's response and side effects. The administration process and dosage should be monitored by a healthcare professional.
Contraindications:
Hypersensitivity to docetaxel or other components of the product
Severe liver disease
Undiagnosed or active infections
Pregnancy and breastfeeding (under medical supervision)
Recent chemotherapy or severe blood disorders
Side Effects:
Nausea, vomiting
Loss of appetite
Decreased white blood cell count (leukopenia)
Fatigue, headache
Hair loss (alopecia)
Mouth sores or ulcers
